NCT05583071
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05583071
Title Methotrexate, Tafasitamab, Lenalidomide and Rituximab in Patients With PCNSL (MTR2)
Acronym MTR²
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Cologne
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU

Facility Status City State Zip Country Details
Klinikum Stuttgart - Katharienenhospital RECRUITING Stuttgart Baden-Wurttemberg 70174 Germany Details
Universitätsklinikum Freiburg NOT_YET_RECRUITING Freiburg im Breisgau Baden-Würtemberg 79106 Germany Details
University of Cologne NOT_YET_RECRUITING Cologne Germany 50937 Germany Details
Universitätsklinikum Hamburg-Eppendorf NOT_YET_RECRUITING Hamburg Hamurg 20246 Germany Details
Universitätsklinikum Essen NOT_YET_RECRUITING Essen Nordrhein Westphalen 45147 Germany Details
Charité - Universitätsmedizin Berlin NOT_YET_RECRUITING Berlin State of Berlin 12203 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field